E-LIB Suche - Ergebnisse für: Emily Greengard

1

A phase 1/2 study of pepinemab in children, adolescents, or..:

Greengard, Emily ; Williams, Robin ; Moriarity, Branden...
Pediatric Blood & Cancer. 71 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

2

Population modeling analyses of crizotinib in pediatric pat..:

Jerry, Li ; Swan, Lin ; Dana, Nickens...
Pediatric Blood & Cancer. 71 (2024) 9 - p. , 2024

Link: https://doi.org/10.1002/..

3

Population Pharmacokinetics and Exposure‐Safety Relationshi..:

Zhou, Xiaofei ; Mould, Diane R. ; Yuan, Ying...
The Journal of Clinical Pharmacology. 62 (2022) 2 - p. 206-219 , 2022

Link: https://doi.org/10.1002/..

4

CTIM-15. FIRST-IN-HUMAN PHASE 1 STUDY OF CD200 ACTIVATION R..:

Neil, Elizabeth ; Eaton, Anne ; Lunn, Shannon...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi52-vi53 , 2021

Link: https://doi.org/10.1093/..

5

Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemo..:

Lee, Adam M. ; Ferdjallah, Asmaa ; Moore, Elise...
International Journal of Molecular Sciences. 22 (2021) 20 - p. 11168 , 2021

Link: https://doi.org/10.3390/..

6

Charting a path for prioritization of novel agents for clin..:

Whittle, Sarah B. ; Offer, Katharine ; Roberts, Ryan D....
Pediatric Blood & Cancer. 68 (2021) 9 - p. , 2021

Link: https://doi.org/10.1002/..

7

Safety, tolerability and pharmacokinetics of crizotinib in ..:

Greengard, Emily ; Mosse, Yael P. ; Liu, Xiaowei...
Cancer Chemotherapy and Pharmacology. 86 (2020) 6 - p. 829-840 , 2020

Link: https://doi.org/10.1007/..

8

Prognostic Factors for Development of Subsequent Metastases..:

Basile, Patrick ; Greengard, Emily ; Weigel, Brenda.
Sarcoma. 2020 (2020) - p. 1-7 , 2020

Link: https://doi.org/10.1155/..

9

Henoch-Schönlein Purpura Presenting in Association With Neu..:

Alfath, Zineb ; Ferdjallah, Asmaa ; Greengard, Emily...
Frontiers in Pediatrics. 8 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

10

The incidence of pediatric malignant soft tissue tumors of ..:

Liszewski, Walter ; Maguiness, Sheilagh ; Greengard, Emily.
Pediatric Dermatology. 35 (2018) 6 - p. , 2018

Link: https://doi.org/10.1111/..

11

A phase I clinical study to evaluate safety of orally admin..:

Fritz, Sara E. ; Henson, Michael S. ; Greengard, Emily...
Veterinary Medicine and Science. 2 (2016) 3 - p. 179-190 , 2016

Link: https://doi.org/10.1002/..

12

Strategies for New Agent Development in Pediatric Sarcomas:

, In: Sarcomas of Bone and Soft Tissues in Children and Adolescents; Pediatric Oncology,

Greengard, Emily G. ; Weigel, Brenda J. - p. 149-164 , 2020

Link: https://doi.org/10.1007/..

13

Predictors of differential response to induction therapy in..:

Pinto, Navin ; Naranjo, Arlene ; Hibbitts, Emily...
European Journal of Cancer. 112 (2019) - p. 66-79 , 2019

Link: https://doi.org/10.1016/..

14

Molecularly Targeted Therapy for Neuroblastoma:

Greengard, Emily G.
Children. 5 (2018) 10 - p. 142 , 2018

Link: https://doi.org/10.3390/..

15

Critical hypercalcemia following discontinuation of denosum..:

Gossai, Nathan ; Hilgers, Megan V. ; Polgreen, Lynda E..
Pediatric Blood & Cancer. 62 (2015) 6 - p. 1078-1080 , 2015

Link: https://doi.org/10.1002/..